Analysis of gene expression during the first 10 weeks following PEG-interferon-alfa2B/ribavirin treatment of a group of hepatitis C raments

被引：0
|
作者：
Taylor, Milton W.
Tsukahara, Takurna
Kwo, Paul
机构：
[1] Indiana Univ, Bloomington, IN USA
[2] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
283
引用
收藏
页码：365A / 365A
页数：1
相关论文
共 50 条
  • [21] An interim analysis of the response to treatment of chronic hepatitis C with interferon-alfa-2b and ribavirin in a population.
    Edelstein, MA
    Ly, D
    Saab, S
    Weston, S
    Lunn, A
    Garrett, B
    Han, SH
    GASTROENTEROLOGY, 2000, 118 (04) : A1436 - A1436
  • [22] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [23] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1493 - 1499
  • [24] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [25] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [26] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    McHutchison, JG
    Gordon, SC
    Schiff, ER
    Shiffman, ML
    Lee, WM
    Rustgi, VK
    Goodman, ZD
    Ling, MH
    Cort, S
    Albrecht, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1485 - 1492
  • [27] Treatment outcome in patients with chronic hepatitis C treated with different pegylated(PEG) interferon alfa-2b plus ribavirin regimens
    Zhang, YT
    Levendoglu, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1033 - 1033
  • [28] High dose consensus interferon and ribavirin for treatment of chronic Hepatitis C infection in patients who are resistant to PEG-Interferon alfa-2b and ribavirin: Preliminary results
    Fernandez, AA
    Singh, S
    Victor, A
    Santiago, M
    Rothstein, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S93 - S94
  • [29] Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study
    Mazzaro, C
    Zorat, F
    Caizzi, M
    Donada, C
    Di Gennaro, G
    Dal Maso, L
    Carniello, G
    Virgolini, L
    Tirelli, U
    Pozzato, G
    JOURNAL OF HEPATOLOGY, 2005, 42 (05) : 632 - 638
  • [30] Interferon-alfa2b in combination with ribavirin for the treatment of chronic hepatitis C in children.
    Gonzalez-Peralta, R
    Haber, BA
    Jonas, M
    Martin, S
    Lang, T
    Geffner, M
    Albrecht, J
    HEPATOLOGY, 2002, 36 (04) : 311A - 311A
12345